Physician profile
Philip E Larkins
NPI 1659375103
$678.22
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $60.87 · 2021: $308.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $249.00 | 2021 | |
| Horizon Therapeutics Plc | $137.94 | 2019-2021 | |
| Smith+Nephew, INC. | $104.72 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $70.18 | 2019 | |
| Melinta Therapeutics, LLC | $51.93 | 2019 | |
| Baudax Bio INC. | $20.83 | 2021 | |
| Nevro Corp. | $17.15 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.05 | 2020 | |
| Tactile Systems Technology INC | $12.42 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Larkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.